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Summary This review summarizes the microbiology, diagnosis and management of infective
endocarditis (IE) due to anaerobic bacteria. Anaerobic bacteria are an uncommon but important
cause of IE. Most cases are caused by the anaerobic and microaerophilic streptococci Propioni-
bacterium acnes, Bacteroides fragilis and Clostridium species. Predisposing factors and signs
and symptoms of IE caused by anaerobic bacteria are similar to those seen in IE due to faculta-
tive anaerobic bacteria with the following exceptions: there is a lower incidence of pre-existing
valvular heart disease, a higher incidence of thromboembolic events and a higher mortality rate
with anaerobic IE. The gastrointestinal tract is the most common source for B. fragilis group
IE, the head and neck are the most common origin for Fusobacterium and Bacteroides species,
and the head and neck or genitourinary tract is the most common source for Peptostrepto-
coccus species. Multiple mycotic aneurysms are a common complication with anaerobic IE.
Others include valvular destruction, aortic-ring abscess, aortitis, cardiogenic shock, dysrrhyth-
mias and septic shock. The mortality rate for patients with anaerobic IE ranges from 21 to 43%.
Treatment of anaerobic IE includes the use of antimicrobial effective against these organisms.
Surgical intervention may be indicated in some patients.
© 2008 Elsevier Masson SAS. All rights reserved.
Résumé Cette revue résume la microbiologie, le diagnostic et la prise en charge des endo-
cardites infectieuses (EI) dues à des germes bactériens anaérobies. Les bactérie anaérobies
sont des germes rarement isolés mais constituent une cause importante d’EI. La plupart des
cas sont secondaires à des streptocoques Propionibacterium acnes, anaérobies, Bacteroides
fragilis et Clostridium. Les facteurs favorisants, les signes et les symptômes des EI causés par
des germes anaérobies sont similaires à ceux observés dans les EI liées à des germes bactériens
anaérobies facultatifs avec cependant les exceptions suivantes : il y a une incidence moindre de
ngton DC 20016, USA. Fax: +1 202 244 6809.
edu.
08 Elsevier Masson SAS. All rights reserved.
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patients ayant une EI à anaérobie varie de 21 à 43%. Le traitement d’une EI à anaérobie inclue
le traitement antimicrobien efﬁcace contre ces micro-organismes. L’indication opératoire peut
être indiquée chez certains patients.
© 2008 Elsevier Masson SAS. All rights reserved.
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nfections due to anaerobic bacteria are common, and can
e serious and life-threatening. The recent increase in the
ecovery of these organisms from all infectious sites [1],
ncluding bacteraemia [2], has led to greater appreciation
f the role anaerobes play in infections at all body sites,
ncluding infective endocarditis (IE).
As the main components of the bacterial ﬂora on nor-
al human skin and mucous membranes, anaerobes are a
ommon cause of endogenous bacterial infections. Because
f their fastidiousness, they are difﬁcult to isolate from
nfected sites and are often overlooked. Their exact fre-
uency is hard to ascertain because of the inconsistent use
f adequate methods for their isolation and identiﬁcation.
he lack of directing adequate antimicrobial therapy against
hese organisms may lead to clinical failures and com-
lications and increase mortality. Their isolation requires
ppropriate methods of collection, transportation and cul-
ivation of the specimens. Treatment of anaerobic infection
s complicated by their polymicrobial nature, and by the
low growth and the growing resistance to antimicrobials
f anaerobic bacteria.
IE due to anaerobic bacteria is an uncommon event,
ccounting for 2—16% of all cases of IE over the past three
ecades [3—6]. This review describes the microbiology and
anagement of IE due to anaerobic bacteria.
icrobiology
taphylococcus aureus, Streptococcus viridians, groups A,
and G streptococci and Enterococcus species are the
ost common microorganisms that cause IE [7—9]. Strep-
ococcus viridans accounts for 50—60% of subacute disease.
treptococcus anginosus causes both acute and suba-
ute infection, accounting for 15% of streptococcal cases;
pproximately 5% of subacute cases are due to nutrition-
lly variant streptococci. Most cases involving Enterococcus
pecies, which are the third most common cause of IE,
re subacute and are generally from a gastrointestinal or
enitourinary tract source, and often reﬂect underlying
bnormalities of the large bowel (e.g., ulcerative colitis,
olyps, cancer). Group B streptococci occur often in preg-
ant women and elderly patients with underlying diseases
p
h
g
re.g., cancer, diabetes, alcoholism); groups A, C and G
treptococcal IE resemble that of Staphylococcus aureus
30—70% mortality rate) with suppurative complications;
taphylococcus aureus is the most common cause of all
orms of IE, has a mortality rate of 40—50% and is asso-
iated with intravascular lines; many of the isolates are
urrently methicillin-resistant. Coagulase-negative staphy-
ococci cause subacute disease. Pseudomonas aeruginosa
enerally induces acute infection often requiring surgery
or cure. The Haemophilus aphrophilus, Actinobacillus acti-
omycetemcomitans, Cardiobacterium hominis, Eikenella
orrodens, Kingella kingae organisms (HACEK) generally
ause subacute disease and account for about 5% of cases.
ungi (Candida and Aspergillus species) primarily cause sub-
cute disease. Bartonella species are common in individuals
ith extremely substandard hygiene.
Anaerobic bacteria are an uncommon but important
ause of IE, accounting for 2—16% of all cases. Most
ases of anaerobic IE are caused by the anaerobic and
icroaerophilic streptococci Propionibacterium acnes and
. fragilis [10,11].
The apparent increase in number of reported cases of
naerobic IE noted in recent years may be explained by the
ncreased frequency of polymicrobial bacteraemias [2], the
ecreased frequency of ‘‘culture-negative’’ cases because
f improved techniques employed in clinical microbiology
aboratories, making culture-negative cases less frequent
oday than in previous years [12,13], the increased use
f prosthetic intravascular devices, and improvements in
icrobiological methods. Polymicrobial IE is more common
n drug addicts (2—9% of cases) [4].
Past studies have described 433 patients with IE due to
naerobic bacteria (Table 1 ). In a review of 1046 cases of
E from 1963 to 1969, 14 (1.3%) were caused by anaerobes
3]. Twelve were due to anaerobic streptococci, one was
aused by Bacteroides species and one by a diphtheroid. An
dditional 33 new cases were also presented. Polymicrobial
nfection was observed in eight (24%) patients, mostly due to
revotella melaninogenica or peptostreptococci mixed with
acultative streptococci. Septic shock was observed in three
atients with anaerobic IE (due to Prevotella oralis, Pro-I. Brook
valulopathie pré-existante, une incidence plus élevée des complications thromboemboliques
et une mortalité plus élevée avec les EI à germes anaérobies. La sphère gastro-intestinale est
la cause la plus fréquente d’EI due à B. fragilis, la tête et le cou étant les origines les plus
fréquentes de Fusobacterium et de Bacteroides, la tête et le cou ainsi que la sphère génito-
urinaire étant les causes les plus fréquentes de germes Peptostreptococcus. Les anévrismes
mycotiques multiples sont une complication fréquente des EI anaérobies. Les autres compli-
cations incluent les dégâts valvulaires, les abcès annulaires, les lésions aortiques, le choc
cardiogénique, les arythmies cardiaques et le choc septique. Le taux de mortalité pour lesionibacterium acnes and C. perfringes) and one case with
ypotension (caused by C. cochlearium). Nastro and Fine-
old [14] reported a single case of IE due to B. fragilis and
eviewed 37 cases of IE due to anaerobic Gram-negative
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Table 1 Literature summary of endocarditis due to anaerobic bacteria.
Organism Number of patients Predisposing conditionsa Reference
Anaerobic Gram-negative bacilli 14 Gastrointestinal, respiratory tract,
congenital heart disease
3
27 Gastrointestinal, respiratory tract,
rheumatic or congenital heart
disease
14
42 Gastrointestinal, genitourinary,
skin and lung
15
28 Gastrointestinal, genitourinary,
skin and lung
16
11 17
2 18
2 19, 21
1 Orthodontic procedure 20
1 74
1 Intravenous drug abuse 75
1 76
1 89
Subtotal 131
Fusobacterium species 5 Head and neck infections 3
10 Head and neck infections 14
15 Head and neck infections 15
8 Intravenous drug abuse 22
1 Dental abscess 29
Subtotal 39
Anaerobic Gram-positive cocci 51 15
5 Infective arthritis, prosthetic valve 44
Subtotal 56
Veillonella species 7 15
7 Prosthetic valves 60—66,70
1 Intravenous drug abuse 75
Subtotal 15
Clostridium species 8 3
17 15
17 Intravenous drug abuse 30
1 Prosthetic valve 31
1 Splenic abscess 32
1 Renal allograft 33
1 Colonic carcinoma 34
1 35
2 Post-partum and colonic carcinoma 36
26 Intravenous drug abuse, carcinoma
of the colon or cervix
38
Subtotal 75
Actinomyces species 1 15
36 57
2 58,59
1 Intravenous drug abuse 75
Subtotal 40
Eubacterium species 3 15
1 71
Subtotal 4
Propionibacterium acnes 5 3
2
4Cardiac surgery 48,49
50—53
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Table 1 (Suite ).
Organism Number of patients Predisposing conditionsa Reference
36 Prosthetic valves and materials 54
15 Congenital heart disease 55
11 Prosthetic valves 56
Subtotal 73
Total 433
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oPredisposing condition(s) was given only if known.
acilli (AGNB), where polymicrobial infections were found
n ﬁve (13.5%). IE due to AGNB was more invasive and
estructive compared with viridans streptococci, embolic
omplications were common and the mortality rate was
8%. In another review of 66 cases, seven (10.6%) were
aused by anaerobes and three of seven were polymicrobial
4].
Finegold, in 1977, summarized 204 cases of anaero-
ic IE [15]. These included 51 cases due to anaerobic
ram-positive cocci, 42 AGNB (including 15 B. fragilis),
7 Clostridium species (including nine C. perfringens), 15
usobacterium species (including seven F. necrophorum and
hree F. nucleatum), seven Veillonella species, four Lac-
obacillus species, three Eubacterium species and one
ctinomyces species.
Masri and Grieco [16] presented a case of IE caused by
acteroides species and reviewed 27 cases. The port of entry
as gastrointestinal in ﬁve, genitourinary in three, skin in
wo and lung in two. Pre-existing heart disease was noted in
5, two each were diabetic or had decubitus ulcers and one
sed heroin.
Cohen et al. [17] described 11 cases of IE due to Bac-
eroides species. Bisharat et al. [18] presented two cases
f IE due to B. fragilis. Le Goff et al. reported a patient
ith B. fragilis IE causing portal thrombosis [19] and Bac-
hion et al. [20] presented a patient with sinus tachycardia
nd ﬁrst-degree atrioventricular block that had B. fragilis IE
n a bicuspid aortic valve, complicated with severe aortic
egurgitation, ring abscess and sinus-of-Valsalva aneurysm
xtending to mitroaortic ﬁbrous continuity. The patient had
n orthodontic procedure complicated with a dental abscess
month prior and was treated with combined clavulanate-
moxicillin antibiotic therapy. The B. fragilis isolate was
esistant to metronidazole. He eventually underwent suc-
essful aortic homograft implantation and mitral valve
epair with residual ﬁrst-degree atrioventricular block.
Kentos et al. [21] described a patient with an indo-
ent course of IE due to Prevotella bivia that caused
ultiple systemic emboli for at least for 7 months. Eight
ases of Fusobacterium-species IE have been summarized
y Vedire et al. [22]. Most of these involved adult intra-
enous drug abusers [23—26]. Five had no history of
alvular heart disease [23—27]. None of these patients had
emierre’s syndrome, the condition most often associated
ith fusobacterial bacteraemia. F. nucleatum was the most
ommon isolate [23—25,28]. F. necrophorum was one of sev-
ral isolates in one adult [26] and a monomicrobial isolate
n another [22]. This organism was the sole pathogen in an
p
a
[
tnfant with a structurally normal heart [27]. Six of the eight
ases of Fusobacterium species were managed successfully
ith medical treatment alone, without the need for valve
eplacement [23,26,28]. Goolamali et al. [29] reported an
dditional case of Fusobacterium-species IE in a patient with
spinal abscess and mitral valve IE secondary to an asymp-
omatic dental abscess.
Kolander et al. [30] reported one case of C. bifermentans
E, and reviewed 16 other cases of clostridial IE. None
f the patients had conditions predisposing to infection.
lvarez-Elcoro et al. [31] reported on a patient with
wo prosthetic valves who presented with IE caused by
. perfringens.
Robles et al. [32] reported a case of prosthetic
alve endocarditis and splenic abscess caused by
. clostridiformis. Muakkassa et al. [33] described a
enal allograft patient IE due to C. ramosum. Ridgway et
l. [34] reported a fatal case of IE due to C. septicum in
patient with underlying colonic carcinoma. Cohen et al.
35] reported a patient with C. septicum IE complicated
y aortic-ring abscess and aortitis. C. perfringens post-
artum and colonic carcinoma IE was found in two patients
36].
Mixed infection due to Pseudallescheria boydii and
. limosum was found on a prosthetic dura mater aortic
alve homograft in a patient [37]. While this patient had
. limosum only growing in blood cultures, both organ-
sms were isolated from the surgically resected aortic
alve.
Durmaz et al. [38] reported a patient with IE due to
. histolyticum and reviewed 25 cases of clostridial IE. The
ost common species was C. perfringens [39—43]. How-
ver, only 14 have detailed clinical information for the
ajor characteristics of clostridial IE. Two were associated
ith intravenous drug abuse and subacute presentation was
ocumented in six. Carcinoma of the colon or cervix was
ocumented in two cases. Peripheral emboli were reported
n four cases, coexistent atypical pneumonia and cardiac
ailure was documented in one case [41], emboli were doc-
mented in one case [42] and hemiplegia was reported in
nother [40]. An echocardiogram indicated vegetations on
he tricuspid valve [39], on the aortic wall at the junction
ith a Dacron prosthesis [39] and below the mitral annulus
f the left ventricular wall [42]; a para-aortic abscess was
resent in another case [43]. Vegetations were revealed at
utopsy on the tricuspid and pulmonary valves in one case
41]. Involvement of the tricuspid valve, the mitral valve,
he aortic valve or both was documented in all other cases;
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•Infective endocarditis caused by anaerobic bacteria
infection of prosthetic valves was reported in four cases
[40,41,43].
IE caused by peptostreptococci is currently rare [15].
Cone et al. described a case and reviewed ﬁve others, which
have been described in detail, and two additional cases men-
tioned in a review of anaerobic infective arthritis [44]. All
but one of the cases involved a prosthetic valve and in three
instances the organism was isolated from only the infected
valve. In four patients the aortic valve was involved and
ﬁve of the patients survived with appropriate antimicrobial
therapy. Embolic phenomena were conﬁrmed in only one
patient.
Propionibacterium acnes has been associated with sev-
eral cases of pacemaker-associated IE [45-47]. It was also
recovered from an adolescent 6 months after recurrent
surgery for a congenital cardiopathy [48] and from an ado-
lescent with Propionibacterium acnes IE 8 months after
valvoplasty and placement of a mitral Carpentier ring for
mitral valve prolapsed [49]. Propionibacterium acnes caused
paravalvular abscess associated with prosthetic-valve IE
[50], IE complicated by intraventricular [51] or aortic root
abscess [52], and acute dehiscence of a valve prosthesis 5
years after implantation [53].
The role of Propionibacterium species in IE in 36
patients was summarized recently [54]. In most cases,
infection was protracted, with minimal signs in the early
stages. Fourteen cases (42.4%) involved native valves, 16
(48.5%) involved prosthetic valves and three (9.1%) were
associated with other intracardiac prosthetic material.
Intracardiac abscesses were encountered in 28.6% of native-
valve endocarditis and in 52.9% of cases of prosthetic-valve
endocarditis caused by Propioibacterium species. Most of
these (70.6%) required surgical intervention. Several fac-
tors delayed institution of appropriate therapy and may have
contributed to abscess formation, including an indolent clin-
ical course, negative or delayed culture results, and the
tendency to consider this organism as a blood-culture conta-
minant. The data support careful clinical evaluation before
disregarding a blood-culture isolate of Propionibacterium
species as a skin contaminant and consideration of this bac-
terium as a potential cause of apparently culture-negative
IE.
Lalani et al. [55] examined the clinical features, compli-
cations and outcomes of 15 patients with Propionibacterium
IE using the International collaboration on endocarditis
merged database (ICE-MD) and the ICE prospective cohort
study (ICE-PCS), and compared the results to 28 cases
reported previously in the literature. In the ICE database, 11
of 15 patients were male with a mean age of 52 years. Pros-
thetic valve endocarditis occurred in 13 of 15 cases and three
patients had a history of congenital heart disease. Clinical
ﬁndings included valvular vegetations (nine patients), car-
diac abscesses (three), congestive heart failure (two) and
central nervous system emboli (two). Most patients were
treated with beta-lactam antibiotics alone or in combi-
nation for 4—6 weeks. Ten of the 15 patients underwent
valve-replacement surgery and two patients died. Similar
ﬁndings were also noted on review of the cases in the
literature. The study suggests that risk factors for Propi-
onibacterium IE include male sex, presence of prosthetic
valves and congenital heart disease. The clinical course is
characterized by complications such as valvular dehiscence,
•
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ardiac abscesses and congestive heart failure, and treat-
ent may require a combination of medical and surgical
herapy.
Delahaye et al. [56] studied 11 patients with Propioni-
acterium acnes IE and reviewed an additional 20 published
ases. They concluded that even though Propionibacterium
cnes IE is rare, its prevalence is probably underestimated. It
ffected mostly men (71%) and occurred at all ages (children
our of 31 cases). An entry point, probably cutaneous, was
arely conﬁrmed. Propionibacterium acnes IE often devel-
ps on a valve prosthesis (42%) and embolisms are common
61%). The infective site was usually aortic (55%). The often-
ubtle symptoms and slow growth of the organism in vitro
ade the diagnosis more difﬁcult, which is often made at
late stage, when valvular and perivalvular destruction has
ecome major.
Dutton and Inclin [57] reviewed 86 cases of actinomyco-
is affecting the heart, including 30 (35%) with IE mostly of
he mitral and/or aortic valves. Schwartz and Christoff [58]
escribed a case with IE due to Actinomyces, and Julian et
l. [59] reported a patient with IE caused by Actinomyces
iscosus.
Seven cases of IE due to Veillonella species were
eported. These included V. alcalescens [60—62], V. dispar
63,64] and V. parvula [65], or the currently renamed
. Parvula [66] and V.montpellierensis [67]. One patient had
o history of fever and another had no pre-existing valvu-
ar disease [62]. Five patients had an infected mitral valve;
our of the ﬁve had prosthetic valves and one patient had
itral and aortic IE [66]. All patients had a positive blood
ulture except two, for whom the diagnosis was made by cul-
uring the valve [60,65]. Veillonella species have also been
solated from intravenous drug abusers with polymicrobial IE
25]. V. parvula was isolated from a lung abscess in a patient
ith echocardiographic vegetations, but the blood cultures
ere negative [65].
athogenicity
he development of IE evolves several stages. Bacter-
emia (nosocomial or spontaneous) enables the organisms
o adhere to the valves and invade the valvular leaﬂets [68].
he organisms causing native-valve IE origination depend on
he events leading to bacteraemia as well as the ability of
hese organisms to adhere to the vascular endothelium. The
ort of entry of bacteroides and clostridia is generally the
astrointestinal tract and the female genital tract; anaero-
ic cocci generally originate from the respiratory tract [10].
acteraemia due to aerobic and anaerobic bacteria can be
nduced following numerous procedures [69]. The rate of
acteraemia after these procedures is:
periodontal surgery (88%);
tooth extraction (60%);
tonsillectomy (35%);
rigid bronchoscopy (15%);
tracheal intubation (10%);
urinary tract catheter insertion or removal (13%);
barium enema (10%);
colonoscopy (6%);
upper endoscopy (4%);
cardiac catheterization (2%).
6 I. Brook
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Table 2 Predisposing conditions for endocarditis
caused by anaerobic bacteria.
Bacteria Predisposing conditions
Bacteroides fragilis group Gastrointestinal (i.e.,
malignancy, appendicitis,
peritonitis, cholecystitis,
aortoduodenal ﬁstula) and
genitourinary infections
(i.e., ovarian malignancy),
diabetes, decubitus ulcers,
drug abuse
Prevotella and
Porphyromonas species
Head and neck (i.e.,
dental procedures and
infections, suppurative
tonsillitis) and pulmonary
infections, drug abuse
Fusobacterium species Head and neck (i.e., dental
procedures and infections,
suppurative tonsillitis) and
pulmonary infections,
congenital heart disease
Peptostreptococcus
species
Dental procedures and
infections, genitourinary
infections, cardiac
prosthetic device, septic
arthritis
Clostridium species Trauma, colonic pathology
and malignancy, cardiac
prosthetic device, drug
abuse, post-abortum
Propionibacterium species Vascular graft, prosthetic
heart valve, intravascular
prosthesis, congenital
heart disease
Eubacterium, Veillonella
species
Vascular graft, a prosthetic
heart valve, intravascular
prosthesis
D
P
w
o
e
m
i
i
b
b
p
a
a70
Intravenous drug abuse can also cause bacteraemia.
The potential for invasive procedures to cause bacter-
emia varies. The rates of bacteraemia (and causative
rganisms) are in:
endoscopy a rate of 0—20% (Staphylococcus epidermidis,
Streptococcus species, diphtheroids);
colonoscopy 0—20% (Escherichia coli, Bacteroides
species);
barium enema 0—20% (enterococci, aerobic and anaerobic
Gram-negative rods);
dental extractions 40—100% (Streptococcus viridans and
oral ﬂora anaerobes, i.e., Prevotella, Eubacterium and
Peptostreptococcus species);
transurethral resection of the prostate 20—40% (Enter-
obacteriacae, enterococci, Staphylococcus aureus);
transesophageal echocardiography 0—20% (Strepto-
coccus viridans, oral ﬂora anaerobes, Streptococcus
species).
Cardiac anomalies or surgery to repair a congenital
nomaly can also predispose to IE (Table 2). IE can also
ccur in prosthetic valves or homographs. When recovered
rom blood cultures, anaerobes that may be contaminants
hould be considered possible pathogens in patients with a
ascular graft, a prosthetic heart valve or an intravascular
rosthesis. In such patients, infections have been caused by
ropionibacterium acnes, Lactobacillus, Eubacterium, Biﬁ-
obacterium or Veillonella species [6,69—73].
The gastrointestinal tract is the most common source
or IE due to B. fragilis [14]. Ovarian carcinoma has also
een associated with B. fragilis: IE [74], the head and neck
re the most common origin for Fusobacterium and AGNB,
nd the head and neck or genitourinary tract are the most
ommon source for peptostreptococci [3,14]. The most com-
on gastrointestinal sources were peritonitis, cholecystitis,
ppendicitis [1,12] and aortoduodenal ﬁstula. Oropharyn-
eal sources include carious teeth, periodontal abscesses
nd suppurative tonsillitis. The most common genitourinary
ract source is the female pelvis [3,14].
Colonic carcinoma has been associated with a fatal case
f IE due to C. septicum [34]. C. perfringens IE was associ-
ted with post-partum and post-abortum [36]. Intravenous
rug abuse can lead to polymicrobial IE. A report of a case
f tricuspid valve polymicrobial IE from three oral anaer-
bes (Actinomyces odontolytica, Veillonella species and
revotella melaninogenica) was reported in an intravenous
rug abuser. The patient was believed to have acquired
hese organisms from his habit of licking the needle in order
o gauge the strength of the cocaine prior to injection [75].
A lower frequency (43—64%) of pre-existing valvular heart
isease has been found in anaerobic IE compared to that
75—100%) due to aerobic bacteria [3,14,76]. However, the
alves involved in patients with anaerobic IE were similar
o those with IE caused by aerobic organisms. The tricuspid
alve is most often infected in anaerobic IE among intra-
enous drug abusers.
The presence of large vegetations with extensive valvu-
ar destruction and congestive heart failure is classically
eported, particularly in B. fragilis IE (60—70%). Periph-
ral embolization is frequently seen (30—54%) and may be
elated to the production of heparinase by this organism
4,15,77].
v
S
t
b
iActinomyces species Head and neck infections,
illicit drug use
iagnosis
atients generally present with malaise, anorexia and
eight loss, chest pain, arthralgia, fever and symptoms
f heart failure [78]. The subtle nature of symptoms of
ndocarditis due to anaerobes can delay the diagnosis for
onths. IE should be suspected in children with congen-
tal heart disease with unexplained fatigue (or anaemia),
n individuals of all ages with fever that may not affected
y antibiotics that have poor coverage against anaerobic
acteria (i.e., macrolydes, glycopeptides, aminoglycosides,
enicillins, cephalosporins except cefoxitin and cefotetan
nd ciproﬂoxacin), in patients with an anaerobic infection
t any site, and in those who have sudden onset of sepsis or
ascular lesions in their soft tissues or mucous membranes.
igns and symptoms of IE caused by anaerobes are similar
o those seen in IE with aerobic and facultative anaero-
ic bacteria with the following exceptions: there is a lower
ncidence of pre-existing valvular heart disease, a higher
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incidence of thromboembolic events and a higher mortality
rate with anaerobic IE [14,15]. The tricuspid valve is most
often involved in intravenous drug abusers [14,15].
Physical examination generally reveals splenic enlarge-
ment, changing heart murmur, petechiae and evidence
of peripheral emboli or vasculitis, especially in the
mucous membranes. A change in the quality of a car-
diac murmur may also occur. Other ﬁndings are rare
but speciﬁc: Osler nodes, Janeway lesions, Roth spots
and splinter haemorrhages in the nail beds. Several case
deﬁnitions and diagnostic criteria have been published
[79,80].
The course of patients with anaerobic IE may be sub-
acute. However, serious and valvular destructive infection
is common with AGNB [14]. B. fragilis IE is associated
with the formation of large valve vegetations and periph-
eral embolization [81]. Septic emboli occur in 60—70% of
patients with B. Fragilis [3,4,14]. Three of ﬁve patients
with B. fragilis IE had thrombophlebitis, which may be
attributed to heparinase production by this organism
[81,82].
Laboratory tests may be supportive of the diagnosis
of IE although there are no pathognomonic ﬁndings. Ery-
throcyte sedimentation rate is generally elevated, and
serum rheumatoid factor and haematuria are present in
only 25—50% of patients. Haematuria and low serum com-
plement are found in 5—40% of patients [78]. Anaemia
and decreased C3, C4 and CH50 are evident in subacute
IE.
Obtaining cultures for aerobic and anaerobic bacteria,
using the appropriate blood-culture media, is of great impor-
tance. More than a single blood culture should be obtained.
The clinical signiﬁcance of a single positive culture for a
possible contaminant is difﬁcult to determine. If several cul-
tures are obtained and only one is positive, the diagnosis
of IE is uncertain. Examination of pathological specimens
by polymerase chain reaction increases the sensitivity and
speed of detection of Propionibacterium acnes [56]. Chu et
al. [83] used time-based clinical criteria and pulsed-ﬁeld gel
electrophoresis-based molecular criteria to classify a case of
repeat IE due to Propionibacterium acnes as a case of rein-
fection. Performing susceptibility testing for the anaerobic
isolates is most important as microbial resistance to these
drugs has increased in recent years [84].
Echocardiography is an important diagnostic technique
for imaging vegetations. Sensitivity and diagnostic accuracy
have improved with the use of Doppler echocardiography
[85]. Echocardiography is helpful in monitoring regression of
vegetations [8]. Transesophageal and transthoracic echocar-
diography increase the sensitivity for imaging vegetations
[86]. Pulmonary embolic phenomena strongly suggest tricus-
pid disease. Computed tomography (CT) scanning is helpful
for localizing abscesses. CT scanning is also useful to detect
clinically silent emboli, which may account for 20—30% of
all embolic events. Cardiac catheterization can be useful in
determining the degree of valvular damage.Treatment
The treatment of IE mandates the use of bactericidal
antimicrobials (Table 3). The administration of these antimi-
c
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t
t
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robials, such as metronidazole alone or combined with
lindamycin, was more effective in preventing experimen-
al IE due to B. fragilis than were bacteriostatic agents
uch as clindamycin, chloramphenicol [87], cefoxitin or ery-
hromycin. Similar experiences were noted in a limited
umber of patients [88].
Carbapenems (i.e., imipenem, meropenem) should be
ffective for anaerobic IE, including the B. fragilis group
84]. Patients with IE caused by penicillin-susceptible
naerobic microorganisms such as peptostreptococci should
eceive therapy with penicillin G or vancomycin, and
hose unable to receive penicillin should be treated with
etronidazole or clindamycin if the organism is sus-
eptible to these agents. Metronidazole has excellent
ctivity against anaerobic bacteria with the exception of
ram-positive bacilli (including Propionibacterium acnes
nd Actinomyces species) and some anaerobic cocci
84].
Presumptive antimicrobial therapy is based on the
atient’s age, pre-existing cardiac condition and other
isk factors such as intravenous drug abuse, surgery
nd previous episodes of bacteraemia or IE. However,
he susceptibility of anaerobic bacteria to antimicrobial
gents has become less predictable. Resistance to several
ntimicrobials by the B. fragilis group and other anaer-
bic Gram-negative bacilli has increased over the past
ecade [84]. A recent report of a patient with IE due
o B. fragilis had an isolate resistant to metronidazole
20]. It is important, therefore, to perform suscepti-
ility testing to isolates recovered from patients with
E.
For therapy of aerobic and facultative bacteria, a
eta-lactamase-resistant penicillin or vancomycin are cho-
en because of their activity against staphylococci and
treptococci. An aminoglycoside is given for synergis-
ic interaction with those agents against enterococci
nd other streptococcal species and to cover aerobic
r facultative Gram-negative bacilli. If blood cultures
how no growth but the patient responds to treat-
ent, initially selected antibiotics are not stopped
hile other methods of diagnosis are continued. If
lood cultures are positive, antibiotic treatment is
hen based on the susceptibility test results. Ther-
py is given intravenously for 4—6 weeks. Individuals
ith prosthetic intravascular valves are treated for 6
eeks.
Experience with treatment of Propionibacterium acnes
E has shown that despite the high sensitivity of the
rganism to most antimicrobials, a surgical intervention
s very often needed (81%) [56]. Surgical intervention
ay be indicated [89,90] for an abscess of the valve
nnulus or myocardium, two or more embolic events,
upture of the valve leaﬂet or chordae, valvular insufﬁ-
iency, rupture of an aneurysm of the sinus of Valsalva,
onduction disturbances caused by a septal abscess, deteri-
rating cardiac failure and inability to sterilize the blood.
emoval of prosthetic valves may be indicated if medi-
al therapy fails. Although controversial, surgery should
e considered in patients with large and mobile vegeta-
ions before the occurrence of emboli, particularly given
he high risk of emboli in patients with IE due to anaer-
bes.
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Table 3 Antimicrobial agents effective for the therapy of endocarditis caused by anaerobic bacteria.
Antimicrobial Route of administration Dose (interval)
newborn mg/kg/day
Dose (interval) Children
<40 kg mg/kg/day
Dose (interval) adults
and children >40 kg
Penicillin G IV, IM 50,000—100,000 units
(q.8-12h.)
100,000—250,000 units
(q.4h.)
10—20million units/day
Piperacillin IV, IM N/A 200—300 (q.4—6h.) 3—4 g (q.4—6h.)
Ticarcillin IV, IM 150—225 (q.8—12h.) 200—300 (q.4—6h.) 3—4 g (q.4—6h.)
Ticarcillin plus clavulanic acid IV 150—225 (q.8—12h.) 200—300 (q.4—6h.) 3.1 g (q.4—8h.)—6.2 g
(q.6h.)
Ampicillin plus sulbactam IV N/A 50—100 (q.6h) 1.5—3.0 g (q.6h.)
Piperacillin plus tazobactam IV N/A 75 (q.12h.) 3.375 g (q.6h.)
Cefoxitin IM, IV N/A 80—160 (q.4—6h.) 1—2 g (q.4—6h.)
Chloramphenicol IV 25mg once a day 50—75 (q.6h.) 1 g (q.6h.)
Clindamycin IM, IV 10—15 (q.8—12h.) 25—40 (q.6—8h.) 600mg (q.6h.), 900mg
(q.8h.)
Metronidazole IV 15 (q.12h.) 30 (q.6h.) 500—1000 mg
Imipenem IV N/A 40—60 (q.6h.) 250—500mg (q.4—6h.)
Meropenem IV N/A 60—120 (q.8h.) 500—1000mg (q.8h.)
Ertapenem IM, IV N/A 15 (q.12h.) 1.0 g q.24h.
Moxiﬂoxacin IV N/A N/Aa 400mg q.24h.
Tigecycline IV N/A 1.5 initially, than 1
q.12h.a
100mg initially, than
50mg q.12h.
IM: intramuscular; IV: intravenous; N/A: not available.
a Not approved under the age of 18 years.
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Complications
Valvular destruction frequency is greater than that asso-
ciated with viridans streptococcal IE but less than the
destruction that occurs with enterococcal, streptococ-
cal or Gram-negative aerobic bacteria [14,81,91]. Other
complications with anaerobic IE include multiple mycotic
aneurysms [92], emboli to other organs [14], aortic-ring
abscess and aortitis (caballero) [35,93], cardiogenic shock,
dysrrhythmias and septic shock.
The mortality rate for patients with anaerobic IE is
21—43% [3,71]. IE by B. fragilis or Fusobacterium necropho-
rum has been associated with the highest rates of mortality:
46 and 75%, respectively [3,14]. F. necrophorum has been
associated with acute IE, rapid valve destruction and death
[14]. Patients with IE caused by Peptostreptococcus species
or drug addicts with anaerobic IE have a more favourable
prognosis than those with IE due to the B. fragilis group or
Fusobacterium species [94].
The mortality for patients with Propionibacterium acnes
IE is relatively high (15—27%) [54,56].
The high mortality rate observed in some studies of IE due
to anaerobes (64%) might be due to the delay in diagnosis
or in earlier series to the absence of effective bactericidal
antimicrobial agents for the treatment of some anaero-
bic infections [14,73]. Sapico and Sarma [4] observed that
no deaths occurred among seven patients with IE due to
anaerobic or microaerophilic organisms. In a review of 101
cases of polymicrobial IE [95], the survival rate was higher
in patients infected with anaerobes (82%) than in those
infected with aerobes (Streptococcus species 84%, Entero-
coccus species 31%, Staphylococcus aureus 67%). Infections
caused by anaerobic Gram-positive cocci carry a better prog-
nosis than those due to B. fragilis or Fusobacterium species.
Prevention
Antimicrobial prophylaxis for bacterial IE has become
standard and routine in most developed countries. The
antimicrobial prophylaxis guidelines of the American Col-
lege of Cardiology (ACC) and the American Heart Association
(AHA) were revised in 1997 and updated by Medical Letter in
2005 [96,97]; the recommendations were unchanged in the
2006 ACC/AHA guidelines on the management of valvular
heart disease [98]. However, these recommendations were
modiﬁed in 2007 by guidelines by a committee from the
American Heart Association Rheumatic Fever, Endocarditis
and Kawasaki Disease Committee, Council on Cardiovascu-
lar Disease in the Young, the Council on Clinical Cardiology,
the Council on Cardiovascular Surgery and Anesthesia, and
the Quality of Care and Outcomes Research Interdisciplinary
Working Group [99]. The low level of evidence for the efﬁ-
cacy of antibiotic prophylaxis and recommendations against
their systematic use was advocated in two guidelines pub-
lished before the 2007 ACC/AHA Guidelines [100,101].
The major changes in the updated recommendations
include the following:
• the committee concluded that only an extremely small
number of cases of IE might be prevented by antibiotic
prophylaxis for dental procedures even if such prophylac-
tic therapy were 100% effective;673
IE prophylaxis for dental procedures should be rec-
ommended only for patients with underlying cardiac
conditions associated with the highest risk of adverse out-
come from IE;
for patients with these underlying cardiac conditions, pro-
phylaxis is recommended for all dental procedures that
involve manipulation of gingival tissue or the periapical
region of teeth or perforation of the oral mucosa;
prophylaxis is not recommended based solely on an
increased lifetime risk of acquisition of IE;
administration of antibiotics solely to prevent endocardi-
tis is not recommended for patients who undergo a
genitourinary or gastrointestinal tract procedure.
These changes are intended to deﬁne more clearly when
E prophylaxis is or is not recommended and to provide more
niform and consistent global recommendations.
The prophylactic antimicrobial regimen for dental pro-
edures is a single dose of amoxicillin, 2 g orally 1 h before
he procedure [42]. Those allergic to penicillins can be
reated 1 h before the procedure with clindamycin (600mg),
ephalexin (2 g), azithromycin or clarithromycin (500mg).
n those unable to take oral medications 2 g of intramuscu-
ar or intravenous ampicillin, cefazolin or ceftriaxone (1 g
ntramuscular or intravenous) is given 30min before the
rocedure. Patients allergic to penicillin who are unable
o take oral medication can be given clindamycin (600mg
ntramuscular or intravenous) or cefazolin or ceftriaxone (1 g
ntramuscular or intravenous) 30min before the procedure.
onclusions
E due to anaerobic bacteria is a rare condition and accounts
or 2—16% of all cases of IE. Most cases of anaerobic IE
re caused by the anaerobic and microaerophilic strepto-
occi Propionibacterium acnes, B. fragilis and Clostridium
pecies [10]. Predisposing factors and signs and symptoms
f IE caused by anaerobic bacteria are similar to those seen
n IE with facultative anaerobic bacteria. Complications with
naerobic IE include valvular destruction, multiple mycotic
neurysms, aortic-ring abscess, aortitis, cardiogenic shock,
ysrrhythmias and septic shock. Treatment of IE caused by
naerobic bacteria includes the use of antibiotics effective
gainst these organisms.
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